Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check6 days agoChange DetectedRemoved Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center from the Resources section.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision tag updated: added Revision: v3.5.0 and removed Revision: v3.4.3. This metadata change does not modify the study content or presented data.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.4.3 added; v3.4.2 removed.SummaryDifference0.0%

- Check51 days agoChange DetectedStudy status updated from Active, not recruiting to Completed, with enrollment changing from 576 to 598 and the completion date updated to 2026-02-02. Revision updated to v3.4.2.SummaryDifference0.9%

- Check58 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1; the previous version tag was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedThe update adds a Show glossary option and updates page metadata with new dates (2026-01-16 and 2026-01-20) and revision v3.4.0. Older dated entries and capitalization variations, as well as the No FEAR Act data text, were removed or adjusted.SummaryDifference0.2%

Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.